Emerging role of MicroRNA-Based theranostics in Hepatocellular Carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11033-023-08586-z.pdf
Reference105 articles.
1. Chakraborty E, Sarkar D (2022) Emerging therapies for Hepatocellular Carcinoma (HCC). Cancers (Basel) 14:2798. https://doi.org/10.3390/cancers14112798
2. Huang A, Yang X-R, Chung W-Y et al (2020) Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther 5:146. https://doi.org/10.1038/s41392-020-00264-x
3. Morishita A, Oura K, Tadokoro T et al (2021) MicroRNAs in the pathogenesis of Hepatocellular Carcinoma: a review. Cancers (Basel) 13:514. https://doi.org/10.3390/cancers13030514
4. Koustas E, Trifylli E-M, Sarantis P et al (2023) An insight into the arising role of MicroRNAs in Hepatocellular Carcinoma: future diagnostic and therapeutic approaches. IJMS 24:7168. https://doi.org/10.3390/ijms24087168
5. Song SK, Jung WY, Park S-K et al (2019) Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection. PLoS ONE 14:e0216847. https://doi.org/10.1371/journal.pone.0216847
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA;Cell Biochemistry and Biophysics;2024-07-10
2. Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals;Medical Oncology;2023-10-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3